Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women

Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women

Vinayak W Patil1, Rajeev Singhai1, Amit V Patil2, Prakash D Gurav21Department of Biochemistry, Grant Medical College and Sir JJ Group of Hospitals, Mumbai, India; 2Department of Surgery, Government Medical College, Miraj, IndiaAbstract: The aim of our study was to analyze triple-negative (TN) breast...

Full description

Bibliographic Details
Main Authors:	Vinayak W Patil, Rajeev Singhai, Amit V Patil, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-03-01
Series:	Breast Cancer : Targets and Therapy
Online Access:	http://www.dovepress.com/triple-negative-er-pgr-her-2neu-breast-cancer-in-indian-women-a6731

Similar Items

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
by: Patil AV, et al.
Published: (2011-04-01)

Cancer biomarker HER-2/neu in breast cancer in Indian women
by: Singhai R, et al.
Published: (2011-03-01)

Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
by: Barbara Tagliaferri, et al.
Published: (2020-09-01)

Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers.
by: Piotr Dziegiel, et al.
Published: (2009-05-01)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
by: Sasagu Kurozumi, et al.
Published: (2017-05-01)

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
by: Tashima Rumiko, et al.
Published: (2011-10-01)

Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology
by: Sven Kurbel, et al.
Published: (2017-03-01)

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
by: Giuseppe Bronte, et al.
Published: (2019-01-01)

Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study
by: Laura Paleari, et al.
Published: (2020-03-01)

Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast
by: Rama D Pyla, et al.
Published: (2020-01-01)

Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient
by: Deepika Sirohi, M.D., et al.
Published: (2015-12-01)

Alteration in Steroid Hormone and HER2/neu Receptor Status Following Neoadjuvant Chemotherapy in Triple Negative Breast Cancer. Is There Any Hope?
by: Rama Das, et al.
Published: (2021-01-01)

Evaluation of triple hormonal content (ER, PR, and HER\2neu)of breast cancer specimens obtained from breast cancer patients using tru-cut biopsy
by: Mustafa H. Jasim, et al.
Published: (2016-10-01)

HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
by: Wang Xiang-Yang, et al.
Published: (2011-03-01)

HER-2/neu-targeted immunoprevention of breast cancer
by: Sas, Sheena Emm
Published: (2007)

Triple negative breast cancer: an Indian perspective
by: Akhtar M, et al.
Published: (2015-08-01)

Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniques
by: Eman El-Abd, et al.
Published: (2014-09-01)

Spectrum of Breast Carcinoma in Relation to ER, PR and HER2/neu Status with Special Emphasis on Changing Patterns in Recurrence
by: Koushik Sarkar, et al.
Published: (2018-02-01)

3, 3’-diindolylmethane induces apoptosis through reduction of HER2/neu in HER2/neu-overexpressing ovarian and breast cancers
by: Chan-Fan Liang, et al.
Published: (100)

Carcinosarcoma of Breast with Hormone Receptor and Her2/neu Positivity
by: Deepti Agarwal, et al.
Published: (2016-01-01)

The epidemiology of Her-2/ neu and P53 in breast cancer
by: Bernstein Jonine L., et al.
Published: (1999-01-01)

Automatic analysis of HER-2/neu immunohistochemistry in breast cancer
by: Ya-Chi Huang, et al.
Published: (2012)

HER-2/neu amplification and expression in papillary lesion of breast
by: Hsiu-Nan Lee, et al.
Published: (2013)

Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.
by: Sanjib Chaudhary, et al.
Published: (2013-01-01)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Vandana Puri, et al.
Published: (2011-01-01)

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
by: Taha Heba F., et al.
Published: (2021-05-01)

Expression of ER、PR and Her-2/neu in diagnosis of breast cancer sampled by core needle biopsy and modified radical mastectomy.
by: I-Ping-Chen, et al.
Published: (2009)

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients
by: Henry G Kaplan, et al.
Published: (2010-08-01)

Silencing of the HER2/neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER2/neu-Overexpressing Breast Cancer Cells
by: Timo Faltus, et al.
Published: (2004-11-01)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
by: Paolo Peterlongo, et al.
Published: (2021-09-01)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01)

Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
by: Tyler Keay, et al.
Published: (2013-01-01)

Freund's vaccine adjuvant promotes Her2/Neu breast cancer
by: Woditschka Stephan, et al.
Published: (2009-01-01)

The p53 breast cancer tissue biomarker in Indian women
by: Patil V, et al.
Published: (2011-08-01)

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report
by: Lakshmi Sivarajan, et al.
Published: (2011-01-01)

ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
by: Alessandra Monaco, et al.
Published: (2021-09-01)

Suppression of HER2/Neu-Overexpressing Cancers by siRNA against HER2/Neu Proto-Oncogene
by: Zong-Keng Kuo, et al.
Published: (2006)

HER2/neu Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative Study
by: Venkataswamy Eswarachary, et al.
Published: (2017-04-01)

Expression of p53, DCC, and HER-2/neu in Mucinous Carcinoma of the Breast
by: Yung-Hsiang Hsu
Published: (2005-05-01)